Physician profile
Coby Reece
NPI 1497268809
$287.54
in general payments reported to CMS, 2019-2025
9 companies · $73.68 in 2025
The $73.68 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.50 · 2024: $197 · 2025: $73.68.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $109.17 | 2024 | Rytary |
| Abbvie INC. | $38.76 | 2024-2025 | |
| Ge Healthcare | $23.60 | 2025 | |
| Kyowa Kirin, INC. | $22.21 | 2024 | Nourianz |
| Cala Health, INC. | $21.48 | 2024 | Cala Kiq, Cala Trio |
| Teva Pharmaceuticals USA, INC. | $19.66 | 2025 | Austedo Xr |
| Acorda Therapeutics, INC | $19.62 | 2024 | Inbrija |
| Pfizer INC. | $16.54 | 2025 | |
| Amgen INC. | $16.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Coby Reece listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.